Inside the clinical decision support market

The clinical decision support market is evolving quickly. With heavy investor backing and competing strategies around specialization, data depth and distribution, the coming years will determine which companies emerge as lasting leaders at the point of care.

Editor's Pick

Top Story Inside the Clinical Decision Support Market: The Race to Make AI Work at the Point of Care The clinical decision support market is evolving quickly. With heavy investor backing and competing strategies around specialization, data depth and distribution, the coming years will determine which companies emerge as lasting leaders at the point of care. Sponsored The Top-Rated Assistive Devices for Children With Sensory Processing Disorders Presented by Enabling Devices The best assistive devices for children with sensory processing disorders are those that meet their needs. They will enhance their ability to participate more fully in daily activities. Learn More. Final Call: INVEST Digital Health Kicks Off Next Thursday Doors open in days, don't miss the conversations shaping 2026 strategy. Claim your spot to hear candid insights from leaders, compare notes with peers, and leave with actionable ideas you can use immediately. Register Now

Featured News

Your Guide to the Hottest Topics on AI in Healthcare in Dallas Next Week at INVEST Digital Health The conference is scheduled for Thursday, September 18 at Pegasus Park in Dallas in partnership with Health Wildcatters. Register today! Headway Launches Enhanced EHR Platform for Mental Health Providers Headway has expanded its EHR system to include an AI-assisted notes feature and an integrated telehealth capability. LB Pharma Pushes the Biotech IPO Window Open, Bagging $285M for Key Schizophrenia Drug Trial LB Pharmaceuticals found enough investor interest to boost the size of its IPO, which will finance clinical trials in schizophrenia and bipolar depression. The biotech has modified an old Sanofi drug with changes intended to reduce side effects and allow less frequent dosing. Healthcare's Data Orchestra: Why Rising Drug Denials Signal a Need for Better Coordination The real story isn't about denial rates or stakeholders acting as villains. It's about a healthcare system that forces intelligent, well-intentioned professionals to make critical decisions in information silos. Debunked Episode 19: Turmoil at the CDC, Epic's AI Strategy The latest episode of the Debunked podcast explores an ongoing debate questioning the role of payers in healthcare transactions. It also highlights turmoil at the CDC. Racing the Clock: The Life-or-Death Power of Early Drugs-of-Abuse Diagnostics in the Emergency Department Early diagnostics for acute intoxication in the emergency department are about more than just identifying the cause of an overdose. They can enable timely intervention, reduce the risk of fatal outcomes, and open the door to substance use disorder treatment and recovery

Video   OpenAI Announces Key Healthcare Hires OpenAI hired two key new leaders for its healthcare division. The first is Nate Gross, who is the company's head of health strategy. He is the co-founder of both Rock Health and Doximity. The other new hire is Ashley Alexander, who has joined OpenAI as vice president of health products. She comes to the company from Instagram, where she most recently served as co-head of product.

Sponsored The Top-Rated Suppliers of Lu-177 for Cancer Research Presented by SHINE Technologies With carrier-added and noncarrier-added versions available, the right supplier can make the difference between a program that stalls and one that successfully reaches patients. Learn More.

Resources

MedCity FemFwd: Designing Healthcare Spaces for Women In this episode, we're joined by Abbie Clary, executive director of Health for All for CannonDesign, an architecture design company. She discusses why healthcare traditionally hasn't been built around women, and what needs to change. View Now

MedCity News • PO Box 901 • New York, NY unsubscribe